Welcome to the home page of the Real-World Evidence Scientific Working Group (RWE SWG).
Our goals are to:
- Advance the understanding of the RWE research in a precompetitive space
- Engage regulators on providing guidance and/or guiding principles on RWE research
- Facilitate utilization and implementation of RWD and RWE in clinical research and medical product life cycle
- Where appropriate, develop statistical methodologies for evidence synthesis and to advance analysis approaches
- Educate the broader statistical community to understand and contribute to this important area
- Increase statisticians’ leadership roles in cross-functional collaboration
- Communicate statistical perspectives to larger clinical trial community
The RWE SWG was co-founded by Weili He and Martin Ho in early 2018.
Expectations for members:
- Have experience in RWD and RWE research
- Have strong technical skills and strategic thinking
- Have time to take part at working group meetings and complete necessary tasks
- Contribute actively
For more information, please contact Hana Lee at hana.lee@fda.hhs.gov, Hongwei Wang at hongwei.wang@abbvie.com, and Shu Yang at syang24@ncsu.edu.
Note: The phase IV project of the RWE has closed the recruitment of new members.
Our charter can be found here.